ARTICLE | Company News
AmberGen, Werfen deal
March 19, 2012 7:00 AM UTC
Werfen's Inova Diagnostics Inc. subsidiary received rights to two autoantigen biomarkers for primary biliary cirrhosis (PBC) from AmberGen and the Massachusetts General Hospital. Inova will add the b...